Skip to main content

Colonic Diseases

4
Pipeline Programs
3
Companies
10
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
4
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Medtronic
MedtronicNJ - Phillipsburg
8 programs
3
PillCam COLONPhase 31 trial
PillCam™Phase 31 trial
PillCam™Phase 31 trial
Evaluation of the PillCam Colon Capsule Endoscopy (PCCE) Preparation and ProcedureN/A1 trial
Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) Preparation and ProcedureN/A1 trial
+3 more programs
Active Trials
NCT00604292Completed50Est. Mar 2009
NCT00885209Completed127Est. Mar 2009
NCT00885339Completed100Est. Oct 2009
+5 more trials
Pharmbio Korea
Pharmbio KoreaKorea - Seoul
1 program
1
PBK-1701TCPhase 31 trial
Active Trials
NCT03509220Completed235Est. Oct 2018
Alliance Pharmaceuticals
1 program
OxaliplatinN/A1 trial
Active Trials
NCT00250029Completed30Est. Mar 2006

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Pharmbio KoreaPBK-1701TC
MedtronicPillCam™
MedtronicPillCam™
MedtronicPillCam COLON
MedtronicPillCam™
MedtronicEvaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) Preparation and Procedure
MedtronicEvaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) Preparation and Procedure
MedtronicEvaluation of the PillCam Colon Capsule Endoscopy (PCCE) Preparation and Procedure
MedtronicPillCam Colon capsule endoscopy
Alliance PharmaceuticalsOxaliplatin

Clinical Trials (10)

Total enrollment: 1,133 patients across 10 trials

NCT03509220Pharmbio KoreaPBK-1701TC

Safety and Efficacy of PBK-1701TC for Bowel Cleansing Before Colonoscopy

Start: Apr 2018Est. completion: Oct 2018235 patients
Phase 3Completed
NCT01063231MedtronicPillCam™

Evaluation of PillCam™ Colon 2 in Visualization of the Colon

Start: Sep 2009Est. completion: Oct 2010119 patients
Phase 3Completed
NCT00951587MedtronicPillCam™

Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) Night Procedure

Start: Feb 2008Est. completion: Mar 201049 patients
Phase 3Completed
NCT00604162MedtronicPillCam COLON

PillCam™ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon

Start: Oct 2006Est. completion: Oct 2007332 patients
Phase 3Completed
NCT01087528MedtronicPillCam™

Evaluation of PillCam™ Colon 2 in Visualization of the Colon

Start: Jul 2009Est. completion: May 201051 patients
N/ACompleted
NCT00885339MedtronicEvaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) Preparation and Procedure

Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) Preparation and Procedure

Start: Feb 2008Est. completion: Oct 2009100 patients
N/ACompleted
NCT00885209MedtronicEvaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) Preparation and Procedure

Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) Preparation and Procedure

Start: Feb 2008Est. completion: Mar 2009127 patients
N/ACompleted
NCT00604292MedtronicEvaluation of the PillCam Colon Capsule Endoscopy (PCCE) Preparation and Procedure

Evaluation of the PillCam Colon Capsule Endoscopy (PCCE) Preparation and Procedure

Start: Jun 2007Est. completion: Mar 200950 patients
N/ACompleted
NCT00440791MedtronicPillCam Colon capsule endoscopy

Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon

Start: Jun 2006Est. completion: Jul 200740 patients
N/ATerminated
NCT00250029Alliance PharmaceuticalsOxaliplatin

Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen

Start: Apr 2004Est. completion: Mar 200630 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.